A Non-interventional Trial With Avastin as Front-line Treatment for Ovarian Cancer
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2019
Price : $35 *
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Carcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms BOVARI
- Sponsors Roche
- 02 Jan 2019 Status changed from active, no longer recruiting to completed.
- 18 Jun 2018 Planned End Date changed from 31 May 2018 to 30 Sep 2018.
- 18 Jun 2018 Planned primary completion date changed from 31 May 2018 to 30 Sep 2018.